Global Ovarian Cancer Diagnostics Market Size study & Forecast, by Diagnosis Type, by Cancer Type, by End Use, and Regional Analysis, 2023-2030

Description

List of Tables

Global Ovarian Cancer Diagnostics Market is valued at approximately USD 1.53 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.2% over the forecast period 2023-2030. Ovarian cancer is a type of cancer that starts in the ovaries, which are the female organs responsible for producing eggs. This cancer is most commonly found in women aged 50 to 79 and is becoming more prevalent as the world's elderly population grows. Early detection and treatment are key in managing ovarian cancer, and initiatives by governments and organizations are driving market growth. However, a lack of skilled professionals hinder the market growth.

The increasing number of cases of ovarian cancer across the globe is driving the market. According to a report by the National Cancer Institute in the US, the rate of new cases of ovarian cancer is 10.3 per 100,000 women per year, with a death rate of 6.3 per 100,000 women per year. This shows how lethal this disease be. Governments and organizations are investing in research and development for ovarian cancer diagnosis and treatment which is boosting the market growth. such as the Ovarian Cancer Research Alliance (OCRA), a non-profit organization. Additionally, healthcare expenditure for cancer treatment is increasing, allowing patients to access advanced diagnostics and treatment for faster recovery. Market players are also launching innovative products, such as Inex Innovate's OvaCis Rapid test for ovarian cancer detection, which boosts the overall market growth. However, due to costlier cancer treatment it poses challenges to market growth. According to the report of the National Cancer Institute, in 2018, costs for cancer care were estimated at USD 201.19 billion, projected to increase to USD 208.9 billion in 2020 due to population growth and aging. This impact market growth until 2030.

The key regions considered for the Global Ovarian Cancer Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022. The region's growth can also be attributed to favorable government initiatives, increased healthcare expenditure, and the presence of key manufacturers. The American Cancer Society estimates that about 19,710 women in the US would be receiving a new diagnosis of ovarian cancer in 2023, with approximately 13,270 women dying from the disease. Ovarian cancer ranks fifth in cancer deaths among women, in U.S. Asia Pacific is expected to grow significantly over the forecast period, owing to factors such as overall economic development, improved healthcare infrastructure, increased disposable income, and greater consumer awareness.

Major market player included in this report are:

Abcam plc.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Johnson & Johnson Services, Inc.
AstraZeneca plc
Siemens Healthcare GmbH
Quest Diagnostics Incorporated.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories Inc.
Abbott. Laboratories Inc.

Recent Developments in the Market:

In November 2022, Myriad Genetics Inc. announced, it had acquired Gateway Genomics, LLC to strengthen its portfolio of Women's Health products. This move aims to enhance their Women's Health products portfolio, providing personalized genetic tests that can be accessed during and after a woman's reproductive stage. With SneakPeek, Myriad can now offer genetic insights earlier in pregnancy, providing women with valuable data throughout their lifetime. The company's Prequel non-invasive prenatal screen, Foresight carrier screen, and MyRisk Hereditary Cancer Test with Risk Scores for all ancestries are expected to increase revenue.
In November 2022, Roche's VENTANA FOLR1 (FOLR1-2.1) RxDx Assay became the first IHC-based companion diagnostic to receive FDA approval. It can identify ovarian cancer patients eligible for ELAHERE, providing a new option for treatment.
In November 2021, the USFDA approved an imaging drug called Cytalux (pafolcianine) that illuminates ovarian cancer tissue when exposed to fluorescent light, making it easier and more precise for surgeons to remove the cancer.

Global Ovarian Cancer Diagnostics Market Report Scope:

Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Diagnosis Type, Cancer Type, End Use, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Diagnosis Type:

Imaging
Blood Test
Biopsy
Others

By Cancer Type:

Epithelial Tumor
Germ Cell Tumor
Stromal Cell Tumor
Others

By End Use:

Hospital Laboratories
Cancer Diagnostic Centers
Research Institutes
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Ovarian Cancer Diagnostics Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Ovarian Cancer Diagnostics Market, by Diagnosis Type, 2020-2030 (USD Billion)
- 1.2.3. Ovarian Cancer Diagnostics Market, by Cancer Type, 2020-2030 (USD Billion)
- 1.2.4. Ovarian Cancer Diagnostics Market, by End Use, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Ovarian Cancer Diagnostics Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Ovarian Cancer Diagnostics Market Dynamics

3.1. Ovarian Cancer Diagnostics Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Rising prevalence of ovarian cancer
  - 3.1.1.2. Increasing emphasis on early diagnosis & treatment
  - 3.1.1.3. Increase in the number of initiatives by governments
- 3.1.2. Market Challenges
  - 3.1.2.1. Lack of trained professionals
  - 3.1.2.2. High Cost of Diagnosis
- 3.1.3. Market Opportunities
  - 3.1.3.1. Increasing Healthcare Expenditure for Cancer Diagnosis and Treatment
  - 3.1.3.2. Innovative launches by the market players

Chapter 4. Global Ovarian Cancer Diagnostics Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Ovarian Cancer Diagnostics Market, by Diagnosis Type

5.1. Market Snapshot
5.2. Global Ovarian Cancer Diagnostics Market by Diagnosis Type, Performance - Potential Analysis
5.3. Global Ovarian Cancer Diagnostics Market Estimates & Forecasts by Diagnosis Type 2020-2030 (USD Billion)
5.4. Ovarian Cancer Diagnostics Market, Sub Segment Analysis
- 5.4.1. Imaging
- 5.4.2. Blood Test
- 5.4.3. Biopsy
- 5.4.4. Others

Chapter 6. Global Ovarian Cancer Diagnostics Market, by Cancer Type

6.1. Market Snapshot
6.2. Global Ovarian Cancer Diagnostics Market by Cancer Type, Performance - Potential Analysis
6.3. Global Ovarian Cancer Diagnostics Market Estimates & Forecasts by Cancer Type 2020-2030 (USD Billion)
6.4. Ovarian Cancer Diagnostics Market, Sub Segment Analysis
- 6.4.1. Epithelial Tumor
- 6.4.2. Germ Cell Tumor
- 6.4.3. Stromal Cell Tumor
- 6.4.4. Others

Chapter 7. Global Ovarian Cancer Diagnostics Market, by End Use

7.1. Market Snapshot
7.2. Global Ovarian Cancer Diagnostics Market by End Use, Performance - Potential Analysis
7.3. Global Ovarian Cancer Diagnostics Market Estimates & Forecasts by End Use 2020-2030 (USD Billion)
7.4. Ovarian Cancer Diagnostics Market, Sub Segment Analysis
- 7.4.1. Hospital Laboratories
- 7.4.2. Cancer Diagnostic Centers
- 7.4.3. Research Institutes
- 7.4.4. Others

Chapter 8. Global Ovarian Cancer Diagnostics Market, Regional Analysis

8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Ovarian Cancer Diagnostics Market, Regional Market Snapshot
8.4. North America Ovarian Cancer Diagnostics Market
- 8.4.1. U.S. Ovarian Cancer Diagnostics Market
  - 8.4.1.1. Diagnosis Type breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2. Cancer Type breakdown estimates & forecasts, 2020-2030
  - 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Ovarian Cancer Diagnostics Market
8.5. Europe Ovarian Cancer Diagnostics Market Snapshot
- 8.5.1. U.K. Ovarian Cancer Diagnostics Market
- 8.5.2. Germany Ovarian Cancer Diagnostics Market
- 8.5.3. France Ovarian Cancer Diagnostics Market
- 8.5.4. Spain Ovarian Cancer Diagnostics Market
- 8.5.5. Italy Ovarian Cancer Diagnostics Market
- 8.5.6. Rest of Europe Ovarian Cancer Diagnostics Market
8.6. Asia-Pacific Ovarian Cancer Diagnostics Market Snapshot
- 8.6.1. China Ovarian Cancer Diagnostics Market
- 8.6.2. India Ovarian Cancer Diagnostics Market
- 8.6.3. Japan Ovarian Cancer Diagnostics Market
- 8.6.4. Australia Ovarian Cancer Diagnostics Market
- 8.6.5. South Korea Ovarian Cancer Diagnostics Market
- 8.6.6. Rest of Asia Pacific Ovarian Cancer Diagnostics Market
8.7. Latin America Ovarian Cancer Diagnostics Market Snapshot
- 8.7.1. Brazil Ovarian Cancer Diagnostics Market
- 8.7.2. Mexico Ovarian Cancer Diagnostics Market
8.8. Middle East & Africa Ovarian Cancer Diagnostics Market
- 8.8.1. Saudi Arabia Ovarian Cancer Diagnostics Market
- 8.8.2. South Africa Ovarian Cancer Diagnostics Market
- 8.8.3. Rest of Middle East & Africa Ovarian Cancer Diagnostics Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Abcam plc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Recent Developments
- 9.3.2. F. Hoffmann-La Roche Ltd.
- 9.3.3. GlaxoSmithKline plc
- 9.3.4. Johnson & Johnson Services, Inc.
- 9.3.5. AstraZeneca plc
- 9.3.6. Siemens Healthcare GmbH
- 9.3.7. Quest Diagnostics Incorporated.
- 9.3.8. Thermo Fisher Scientific Inc.
- 9.3.9. Bio-Rad Laboratories Inc.
- 9.3.10. Abbott. Laboratories Inc.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Ovarian Cancer Diagnostics Market, report scope
TABLE 2. Global Ovarian Cancer Diagnostics Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Ovarian Cancer Diagnostics Market estimates & forecasts by Diagnosis Type 2020-2030 (USD Billion)
TABLE 4. Global Ovarian Cancer Diagnostics Market estimates & forecasts by Cancer Type 2020-2030 (USD Billion)
TABLE 5. Global Ovarian Cancer Diagnostics Market estimates & forecasts by End Use 2020-2030 (USD Billion)
TABLE 6. Global Ovarian Cancer Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Ovarian Cancer Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Ovarian Cancer Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Ovarian Cancer Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Ovarian Cancer Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Ovarian Cancer Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Ovarian Cancer Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Ovarian Cancer Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Ovarian Cancer Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Ovarian Cancer Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Ovarian Cancer Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Ovarian Cancer Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Ovarian Cancer Diagnostics Market
TABLE 71. List of primary sources, used in the study of global Ovarian Cancer Diagnostics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Ovarian Cancer Diagnostics Market, research methodology
FIG 2. Global Ovarian Cancer Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Ovarian Cancer Diagnostics Market, key trends 2022
FIG 5. Global Ovarian Cancer Diagnostics Market, growth prospects 2023-2030
FIG 6. Global Ovarian Cancer Diagnostics Market, porters 5 force model
FIG 7. Global Ovarian Cancer Diagnostics Market, pest analysis
FIG 8. Global Ovarian Cancer Diagnostics Market, value chain analysis
FIG 9. Global Ovarian Cancer Diagnostics Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Ovarian Cancer Diagnostics Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Ovarian Cancer Diagnostics Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Ovarian Cancer Diagnostics Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Ovarian Cancer Diagnostics Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Ovarian Cancer Diagnostics Market, regional snapshot 2020 & 2030
FIG 15. North America Ovarian Cancer Diagnostics Market 2020 & 2030 (USD Billion)
FIG 16. Europe Ovarian Cancer Diagnostics Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Ovarian Cancer Diagnostics Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Ovarian Cancer Diagnostics Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Ovarian Cancer Diagnostics Market 2020 & 2030 (USD Billion)